C5a受体1促进实验性抗髓过氧化物酶肾小球肾炎的自身免疫、中性粒细胞功能障碍和损伤
该研究利用小鼠模型探讨C5aR1在抗髓过氧化物酶自身免疫及肾损伤效应中的作用。结果显示,C5aR1基因缺失或药理抑制可减少针对MPO的自身免疫、减弱Th1反应、增加Foxp3+调节性T细胞并减少MPO-ANCA生成,这些变化由树突状细胞上的C5aR1介导。肾脏活体显微镜显示C5aR1抑制可消除MPO-ANCA诱导的中性粒细胞滞留和活性氧爆发。
要点
- C5aR1抑制可减轻抗MPO自身免疫和肾小球肾炎。
- C5aR1通过树突状细胞促进自身免疫和肾损伤。
- C5aR1抑制可消除ANCA诱导的中性粒细胞功能障碍。
核心结论
- C5aR1抑制可改善ANCA相关性血管炎中的自身免疫和肾内中性粒细胞活化。
研究设计与样本
- 研究使用小鼠模型,包括C5aR1基因缺失或药理抑制,以及肾脏活体显微镜。
主要发现
- C5aR1基因缺失或药理抑制导致针对MPO的自身免疫减少,Th1反应减弱,Foxp3+调节性T细胞增加,MPO-ANCA生成减少。
- 这些变化由树突状细胞上的C5aR1介导,促进树突状细胞活化,从而促进MPO自身免疫和肾小球肾炎。
- MPO-ANCA诱导肾小球毛细血管内中性粒细胞滞留和活性氧爆发,这些病理行为被C5aR1抑制所消除。
临床怎么用
- C5aR1抑制可能作为ANCA相关性血管炎中替代糖皮质激素的诱导治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prospects for complement-targeted therapy in ANCA-associated vasculitis have been enhanced by a recent clinical trial in which C5a receptor 1 (C5aR1) inhibition safely replaced glucocorticoids in induction treatment. C5aR1 primes neutrophils for activation by anti-neutrophil cytoplasmic antibody (ANCA) and is therefore required in models of glomerulonephritis induced by anti-myeloperoxidase antibody. Although humoral and cellular autoimmunity play essential roles in ANCA-associated vasculitis, a role for C5aR1 in these responses has not been described. Here, we use murine models to dissect the role of C5aR1 in the generation of anti-myeloperoxidase autoimmunity and the effector responses resulting in renal injury. The genetic absence or pharmacological inhibition of C5aR1 results in reduced autoimmunity to myeloperoxidase with an attenuated Th1 response, increased Foxp3+ regulatory T cells and reduction in generation of myeloperoxidase-ANCA. These changes are mediated by C5aR1 on dendritic cells, which promotes activation, and thus myeloperoxidase autoimmunity and glomerulonephritis. We also use renal intravital microscopy to determine the effect of C5aR1 inhibition on ANCA induced neutrophil dysfunction. We found that myeloperoxidase-ANCA induce neutrophil retention and reactive oxygen species burst within glomerular capillaries. These pathological behaviors are abrogated by C5aR1 inhibition. Thus, C5aR1 inhibition ameliorates both autoimmunity and intra-renal neutrophil activation in ANCA-associated vasculitis.
引用
- Dick J, Gan PY, Ford SL, et al. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis. Kidney Int. 2017. PMID: 29241626. doi:10.1016/j.kint.2017.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。